美国科罗拉多州大学的研究小组发现,许多乳腺癌患者在其表面具有雄激素受体,雄激素会刺激肿瘤的生长。詹妮弗·里切尔博士和她的同事们指出,在所有乳腺癌患者中,有超过3/4的具有雄激素受体,因此可能会受益于抗雄激素的疗法。这种治疗方法目前已经用于前列腺癌的治疗。专家们已知某些乳腺癌是在女性激素,诸如雌激素和黄体酮的影响下发展的。一些被广泛使用的治疗乳腺癌药物,往往是通过阻塞雌激素受体,使这些癌 A team from the University of Colorado in the United States found that many breast cancer patients have androgen receptors on their surface and androgen stimulates tumor growth. Dr. Jennifer Richie and her colleagues point out that more than three-quarters of all breast cancer patients have androgen receptors and may therefore benefit from anti-androgenic therapies. This treatment is currently used for the treatment of prostate cancer. Experts know that certain breast cancers develop under the influence of female hormones, such as estrogen and progesterone. Some of the most widely used drugs used to treat breast cancer are often those that block these estrogen receptors